Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Studies by Using Alphacait to Screen Drug Combinations for Advanced Solid Tumor

NCT03299452 is registered in ClinicalTrials.gov with Haining Health-Coming Biotech Co., Ltd. as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03299452 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Studies by Using Alphacait to Screen Drug Combinations for Advanced Solid Tumor
Lead sponsor
Haining Health-Coming Biotech Co., Ltd.
Phase
Phase 2
Overall status
Unknown status
Start date
January 1, 2017
Completion date
December 31, 2020
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic cancer